Cera delivered strong volume-led growth despite severe input cost inflation in brass and gas. Management is confident of surpassing its 18-20% revenue target while maintaining improved margins in H2.
Cera Sanitaryware Ltd has granted 13,650 stock options to eligible employees under its ESOS 2024 scheme. The options feature a five-year vesting schedule and an exercise price set at the face value of Rs. 5 per share.
Cera Sanitaryware released its Q2 FY27 investor communication highlighting revenue of ₹603 crore, EBITDA of ₹84 crore, and PAT of ₹56 crore. The board approved unaudited results for the quarter and half year ended September 30, 2026.
Cera Sanitaryware's board approved re-appointment of Vikram Somany as CMD and Anandh Sundar as Independent Director for 5-year terms starting 2027. Both remain subject to shareholder approval.
Cera Sanitaryware scheduled a board meeting on 4 Nov 2026 to approve Q2/H1 results and re-appoint its CMD and an Independent Director. No financial figures or transaction values are disclosed in this intimation.
Cera Sanitaryware filed a routine Regulation 74(5) certificate confirming the processing and listing of dematerialized shares for the quarter ended September 30, 2026.
Cera Sanitaryware Employees Welfare Trust acquired 2,150 equity shares via market purchase. The transaction, valued at ₹1.21 Crore, increased the trust's holding to 0.05%.
Cera Sanitaryware Limited received reaffirmed credit ratings from CARE Ratings Limited for its bank facilities. The total facility amount under the rating action is ₹100 Crore.
Cera Sanitaryware reports robust 19.5% revenue growth in Q1FY27, but EBITDA margins were severely dented by brass and gas cost spikes alongside one-time worker settlement provisions.
Cera Sanitaryware reported Q1 FY27 revenue of Rs. 486 Crore, up 19.5% year-on-year. PAT stood at Rs. 45.3 Crore despite pressure from elevated input costs.
Cera Sanitaryware Ltd scheduled a board meeting for August 7, 2026. The board will consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Cera Sanitaryware held its 28th Annual General Meeting on July 23, 2026. Shareholders considered and voted on various ordinary and special business resolutions proposed by the company.
Chief Business Officer (Polymers and Emerging Business India) Ramesh Baliga has resigned for personal reasons. He will be relieved from duties on September 30, 2026.
Cera Sanitaryware received reaffirmed credit ratings from Crisil. Its long-term rating is AA/Stable and short-term is A1+ for its bank facilities and commercial paper.
Cera Sanitaryware Ltd submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report outlines sustainability initiatives and operational disclosures.
HDFC Life Insurance Co. Ltd sold 1,50,000 shares (1.16%) of Cera Sanitaryware Limited via open market. The institutional investor's stake now stands reduced to 0.003%.
Cera Sanitaryware announced the vesting of 2,244 stock options under its ESOS 2024 scheme. These options are now exercisable by employees over a five-year period.
Cera Sanitaryware's May 2026 presentation highlights its multi-brand strategy, tech-led manufacturing (3D printing, robotics), and expanding retail footprint in India.
Cera Q4FY26 revenue rose 11.4% YoY to ₹644cr, though EBITDA margins contracted to 15.2% due to elevated brass costs and trade discounts. Management remains optimistic about retail recovery and core brand strength.